(Q37031514)

17 August 2017

1 reference

title

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer (English)

1 reference

17 August 2017

1 reference

Alison K Conlin

1

1 reference

17 August 2017

Andrew D Seidman

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Molecular Diagnosis and Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

11

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

355-360

1 reference

Global cancer statistics, 2002

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Trends in breast cancer by race and ethnicity: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256259

Age as prognostic factor in premenopausal breast carcinoma

21 January 2018

1 reference

12 December 2020

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

1 reference

12 December 2020

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection

1 reference

12 December 2020

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

12 December 2020

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

1 reference

12 December 2020

Individualization of therapy using Mammaprint: from development to the MINDACT Trial

1 reference

12 December 2020

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer

1 reference

12 December 2020

TAILORx: trial assigning individualized options for treatment (Rx)

1 reference

12 December 2020

Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.

1 reference

12 December 2020

Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry

1 reference

12 December 2020

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

12 December 2020

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256259

1 reference

17 August 2017

1 reference